Phase II study of vandetanib or placebo in small-cell lung cancer patients after complete or partial response to induction chemotherapy with or without radiation therapy: National Cancer Institute of Canada Clinical Trials Group Study BR.20 (Q81317582)
Jump to navigation
Jump to search
scientific article published on 01 September 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of vandetanib or placebo in small-cell lung cancer patients after complete or partial response to induction chemotherapy with or without radiation therapy: National Cancer Institute of Canada Clinical Trials Group Study BR.20 |
scientific article published on 01 September 2007 |
Statements
Phase II study of vandetanib or placebo in small-cell lung cancer patients after complete or partial response to induction chemotherapy with or without radiation therapy: National Cancer Institute of Canada Clinical Trials Group Study BR.20 (English)
Andrew M Arnold
Lesley Seymour
Michael Smylie
Keyue Ding
Yee Ung
Brian Findlay
Christopher W Lee
Marina Djurfeldt
Marlo Whitehead
Peter Ellis
Glenwood Goss
Adrien Chan
Jacinta Meharchand
Yasmin Alam
Richard Gregg
Charles Butts
Peter Langmuir
Frances Shepherd
National Cancer Institute of Canada Clinical Trials Group Study BR.20
1 September 2007